Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | MMP9 | P14780 | 12/20 | 0.69 |
| ▸ | MMP2 | P08253 | 10/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.59 |
| ▸ | MMP7 | P09237 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20335103 | 1.00 | SMN1; SMN2 (0.70) | SMN1; SMN2MMP9MMP2KMT2AMEN1 | |
| SCHEMBL20335105 | 1.00 | SMN1; SMN2 (0.70) | SMN1; SMN2MMP9MMP2KMT2AMEN1 | |
| SCHEMBL29776944 | 1.00 | SMN1; SMN2 (0.70) | SMN1; SMN2MMP9MMP2KMT2AMEN1 | |
| SCHEMBL8579007 | 0.87 | MMP9 (0.72) | SMN1; SMN2MMP9MMP2KMT2AMEN1 | |
| SCHEMBL11949521 | 0.86 | NR3C1 (0.72) | SMN1; SMN2MMP9MMP2KMT2AMEN1 | |
| SCHEMBL5863653 | 0.86 | SMN1; SMN2 (0.64) | SMN1; SMN2MMP9MMP2KMT2AKCNA5 | |
| SCHEMBL4133797 | 0.86 | SMN1; SMN2 (0.64) | SMN1; SMN2MMP9MMP2KMT2AKCNA5 | |
| SCHEMBL5191094 | 0.85 | MMP9 (0.89) | MMP9MMP2KMT2AMEN1POLB | |
| SCHEMBL6720186 | 0.85 | MMP9 (0.89) | MMP9MMP2KMT2AMEN1POLB | |
| SCHEMBL5863661 | 0.85 | MMP9 (0.67) | SMN1; SMN2MMP9MMP2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5763436-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5595999-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-01-21 | — | — | US | disclosed |
| US-5583133-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-12-10 | — | — | US | disclosed |
| US-5532232-A | INHIBIT THROMBIN INDUCED PLATELET AGGREGATION; FIBRINOGEN ANTICOAGULANTS IN BLOOD | HOFFMANN-LA ROCHE INC. (US) | 1996-07-02 | — | — | US | disclosed |
| US-5393760-A | Cardiovascular disorders, antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0468231-B1 | Guanidins | HOFFMANN LA ROCHE (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5260307-A | Inhibit thrombin-induced platlet aggregation and clotting of fibrogen in plasma | HOFMANN-LA ROCHE INC. (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0468231-A2 | Guanidins | F. HOFFMANN-LA ROCHE AG (CH) | 1992-01-29 | — | — | EP | disclosed |